MPGES 1 INHIBITOR
Glenmark receives USD 4 mn from Forest Lab as research feeThe company through its Swiss unit has received USD 4 million as research fee payment from Forest Laboratories Inc for the development of n...
Glenmark gets research fee payment from Forest LaboratoriesThe company is expecting an additional payment to support the advancement of the programme, Glenmark Pharmaceuticals said.- Glenmark Q3 net up 5-fold at Rs 213 cr due to strong salesGlenmark Pharmaceuticals today reported nearly five-fold jump in consolidated net profit at Rs 212.91 crore for its third quarter ended Dec...
- Glenmark Pharma set to reap R&D gains despite hiccupsThe research effort combined with good performance in its generics business has made investors lap up its stock in recent quarters.
Glenmark inks drug development pact with Forest LaboratoriesAs part of the agreement, Glenmark will receive up to $ 9 million (around Rs 50 crore) from US-based Forest Laboratories Inc.
Glenmark Pharmaceuticals hits 52-week high on pact with Forest LaboratoriesGlenmark surged over 4% to hit its 52-week high of Rs 519.70 after the company said its subsidiary has signed an agreement with Forest Labs.
Load More- Glenmark Pharma set to reap R&D gains despite hiccups